G-protein-coupled
receptor
30
(GPR30)
is
a
bicarbonate
that
plays
vital
role
in
cellular
responses
to
extracellular
pH
and
ion
homeostasis.
Despite
its
significance,
the
mechanisms
by
which
GPR30
interacts
with
ions
remain
elusive.
There
no
consensus
on
drug
targets
GPR30,
difficulty
pharmacological
analysis
has
limited
biological
discovery
researches
GPR30.
Here,
we
present
cryo-electron
microscopy
structure
of
human
presence
at
3.2
Å
resolution.
Our
reveals
unique
pockets
critical
residues
for
binding
activation.
Functional
assays
demonstrate
mutations
these
impair
bicarbonate-induced
activation,
underscoring
their
importance
function.
This
study
also
provides
insights
into
G-protein
coupling,
highlighting
structural
divergence
between
other
GPCRs.
findings
not
only
advance
understanding
homeostasis
but
pave
way
development
high-affinity
drugs
targeting
therapeutic
interventions
diseases
associated
acid-base
imbalance.
Genes,
Journal Year:
2024,
Volume and Issue:
15(9), P. 1151 - 1151
Published: Sept. 1, 2024
The
precise
regulation
of
pH
homeostasis
is
crucial
for
normal
physiology.
However,
in
tissue
microenvironments,
it
can
be
impacted
by
pathological
conditions
such
as
inflammation
and
cancer.
Due
to
the
overproduction
accumulation
acids
(protons),
extracellular
characteristically
more
acidic
inflamed
tissues
tumors
comparison
tissues.
A
family
proton-sensing
G-protein-coupled
receptors
(GPCRs)
has
been
identified
molecular
sensors
cells
responding
microenvironments.
Herein,
we
review
current
research
progress
pertaining
these
GPCRs,
including
GPR4,
GPR65
(TDAG8),
GPR68
(OGR1),
Growing
evidence
suggests
that
GPR4
are
mainly
pro-inflammatory,
whereas
primarily
anti-inflammatory,
various
inflammatory
disorders.
Both
anti-
pro-tumorigenic
effects
have
reported
this
receptors.
Moreover,
antagonists
agonists
targeting
GPCRs
developed
evaluated
preclinical
models.
Further
warranted
better
understand
roles
pathophysiology
required
order
exploit
them
potential
therapeutic
targets
disease
treatment.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(39)
Published: Sept. 18, 2023
The
canonical
view
of
G
protein–coupled
receptor
(GPCR)
function
is
that
trafficking
tightly
coupled
to
signaling.
GPCRs
remain
on
the
plasma
membrane
(PM)
at
cell
surface
until
they
are
activated,
after
which
desensitized
and
internalized
into
endosomal
compartments.
This
presents
an
interesting
context
for
proton-sensing
because
more
likely
be
activated
in
acidic
compartments
than
PM.
Here,
we
show
prototypical
proton-sensor
GPR65
fully
uncoupled
from
signaling,
unlike
other
known
mammalian
GPCRs.
internalizes
localizes
early
late
endosomes,
where
signal
steady
state,
irrespective
extracellular
pH.
Acidic
environments
stimulate
signaling
PM
a
dose-dependent
manner,
although
still
required
full
response.
Receptor
mutants
were
incapable
activating
cAMP
trafficked
normally,
internalize
localize
Our
results
constitutively
active
suggest
model
changes
pH
reprograms
spatial
pattern
biases
location
surface.
Pflügers Archiv - European Journal of Physiology,
Journal Year:
2024,
Volume and Issue:
476(4), P. 611 - 622
Published: March 22, 2024
Abstract
Low
pH
in
the
gut
is
associated
with
severe
inflammation,
fibrosis,
and
colorectal
cancer
(CRC)
a
hallmark
of
active
inflammatory
bowel
disease
(IBD).
Subsequently,
pH-sensing
mechanisms
are
interest
for
understanding
IBD
pathophysiology.
Tissue
hypoxia
acidosis—two
contributing
factors
to
pathophysiology—are
linked
IBD,
their
interplay
highly
relevant
development
new
therapeutic
options.
One
member
proton-sensing
G
protein-coupled
receptor
(GPCR)
family,
GPR65
(T-cell
death-associated
gene
8,
TDAG8),
was
identified
as
susceptibility
large
genome-wide
association
study.
In
response
acidic
extracellular
pH,
induces
an
anti-inflammatory
response,
whereas
two
other
receptors,
GPR4
GPR68
(ovarian
1,
OGR1),
mediate
pro-inflammatory
responses.
Here,
we
review
current
knowledge
on
role
these
receptors
IBD-associated
fibrosis
cancer,
well
colitis-associated
(CAC).
We
also
describe
emerging
small
molecule
modulators
opportunities
treatment
IBD.
Pflügers Archiv - European Journal of Physiology,
Journal Year:
2024,
Volume and Issue:
476(4), P. 445 - 455
Published: Feb. 10, 2024
Abstract
Changes
in
extracellular
proton
concentrations
occur
a
variety
of
tissues
over
range
timescales
under
physiological
conditions
and
also
accompany
virtually
all
pathologies,
notably
cancers,
stroke,
inflammation
trauma.
Proton-activated,
G
protein
coupled
receptors
are
already
partially
active
at
their
activity
increases
with
rising
concentrations.
Their
ability
to
monitor
report
changes
hence
pH
appears
be
involved
processes,
it
is
likely
mirror
some
cases
promote
disease
progression.
Unsurprisingly,
therefore,
these
pH-sensing
(pHR)
receive
increasing
attention
from
researchers
working
an
expanding
research
areas,
cellular
neurophysiology
systemic
inflammatory
processes.
This
review
looking
progress
made
the
field
pHRs
past
few
years
highlights
outstanding
issues.
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 2, 2024
Acidic
microenvironments
is
a
cancer
progression
driver,
unclear
core
mechanism
hinders
the
discovery
of
new
diagnostic
or
therapeutic
targets.
ASIC3
an
extracellular
proton
sensor
and
acid-sensitive,
but
its
role
in
acidic
tumor
microenvironment
colorectal
not
reported.
Functional
analysis
data
show
that
cells
respond
to
specific
concentration
lactate
accelerate
invasion
metastasis,
main
actor
this
process.
Mechanism
reveal
de
novo
lipid
synthesis
regulatory
process
ASIC3,
down-regulated
increases
interacts
with
ACC1
SCD1,
which
are
key
enzymes
pathway,
interaction
results
increased
unsaturated
fatty
acids,
turn
induce
EMT
promote
overexpression
reduces
TME-enhanced
metastasis.
Clinical
samples
also
exhibit
decreased
expression,
low
expression
associated
metastasis
stage
cancer.
This
study
first
identify
ASIC3-ACC1/SCD1
axis
acid-enhanced
The
pattern
differs
significantly
from
other
types
cancers,
may
serve
as
novel
reliable
marker
for
microenvironmental
cancer,
potentially
target.
Pharmaceuticals,
Journal Year:
2022,
Volume and Issue:
15(12), P. 1444 - 1444
Published: Nov. 22, 2022
Doxorubicin
(Dox)
is
a
widely
utilized
chemotherapeutic;
however,
it
carries
side
effects,
including
drug-induced
immune
thrombocytopenia
(DITP)
and
increased
risk
of
venous
thromboembolism
(VTE).
Currently,
the
mechanisms
for
Dox-associated
DITP
VTE
are
poorly
understood,
an
effective
inhibitor
to
relieve
these
complications
remains
be
developed.
In
this
study,
we
found
that
Dox
significantly
induced
platelet
activation
enhanced
phagocytosis
by
macrophages
accelerated
clearance.
Importantly,
determined
salvianolic
acid
C
(SAC),
water-soluble
compound
derived
from
Danshen
root
traditionally
used
treat
cardiovascular
diseases,
inhibited
Dox-induced
more
effectively
than
current
standard-of-care
anti-platelet
drugs
aspirin
ticagrelor.
Mechanism
studies
with
tyrosine
kinase
inhibitors
indicate
contributions
phospholipase
C,
spleen
kinase,
protein
signaling
pathways
in
activation.
We
further
demonstrated
platelet-cancer
cell
interaction,
which
was
ameliorated
SAC.
Taken
together,
findings
suggest
SAC
may
promising
therapy
reduce
DITP,
VTE,
repercussions
amplified
interaction
tumor
microenvironment.
Clinical Science,
Journal Year:
2023,
Volume and Issue:
137(14), P. 1013 - 1025
Published: July 1, 2023
Abstract
Ovarian
cancer
G
protein-coupled
receptor
1
(OGR1)
(Gpr68)
and
4
(GPR4)
(Gpr4)
are
proton-activated
receptors
that
stimulated
upon
increased
extracellular
acidity.
These
have
various
physiological
pathophysiological
roles
in
renal
acid–base
physiology,
tissue
inflammation,
fibrosis
among
others.
Their
function
injured
tissue,
however,
remains
mostly
unclear.
To
address
this,
we
investigated
their
role
crystalline
nephropathy
by
increasing
the
oxalate
intake
of
GPR4
KO
OGR1
mice.
After
10
days
high-oxalate
recovery,
crystal
content,
histopathology,
filtration
function,
inflammation
were
assessed.
While
deficiency
did
not
show
major
alterations
disease
progression,
mice
had
higher
urinary
calcium
levels
exacerbated
accumulation
accompanied
decreased
creatinine
clearance
urea
excretion
a
presence
regulatory
T
(Treg)
cells
kidney
tissue.
When
lowering
severity
injury,
more
prone
to
develop
nephropathy.
In
this
setting,
displayed
an
activation
immune
system
production
proinflammatory
cytokines
macrophages.
Taken
together,
acute
setting
oxalate-induced
nephropathy,
lack
(GPCR)
does
influence
disease.
deficiency,
increases
deposition
leading
impaired
function.
Thus,
may
be
important
limit
deposition,
which
might
subsequently
relevant
for
pathophysiology
stones
or
other
crystallopathies.
Biochemical Society Transactions,
Journal Year:
2023,
Volume and Issue:
51(1), P. 223 - 232
Published: Feb. 6, 2023
Chronic
kidney
disease
(CKD)
is
characterized
by
progressive
reduction
in
function
and
treatments
aiming
at
stabilizing
or
slowing
its
progression
may
avoid
delay
the
necessity
of
replacement
therapy
increased
mortality
associated
with
reduced
function.
Metabolic
acidosis,
less
severe
stages
acid
stress
continuum,
are
common
consequences
CKD
some
interventional
studies
support
that
correction
slows
to
end-stage
disease.
This
can
be
achieved
mineral
alkali
form
bicarbonate
citrate
salts,
ingestion
diets
fewer
acid-producing
food
components
more
base-producing
components,
a
pharmacological
approach.
In
this
mini-review
article,
we
summarize
potential
mechanisms
involved
beneficial
effects
therapy.
We
also
discuss
perspectives
field
challenges
must
overcome
advance
our
understanding
such
mechanisms.